COPD assessment test for the evaluation of COVID-19 symptoms
Enya Daynes, Charlotte Gerlis, Samuel Briggs‐Price, Paul Jones, Sally Singh
Abstract
There is evidence to demonstrate the ongoing symptoms of COVID-19; however, there are currently no agreed outcomes to assess these symptoms. This study examined the use of the chronic obstructive pulmonary disease (COPD) assessment test (CAT) for patients recovering from COVID-19. 131 patients who were admitted with COVID-19 were followed up over the phone to assess symptoms. The median (IQR) CAT score was 10 (5-16). Cough, phlegm and chest tightness domains were within range for healthy people, but there was evidence of significant breathlessness, loss of energy, and activity and sleep disturbance. The CAT is a useful tool to assess symptoms of COVID-19 recovery.
Topics & Concepts
MedicineCOPDCoronavirus disease 2019 (COVID-19)Internal medicinePulmonary diseasePhlegmPhysical therapySeverity of illnessPneumonia2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineDiseasePathologyAlternative medicineTraditional Chinese medicineInfectious disease (medical specialty)OutbreakChronic Obstructive Pulmonary Disease (COPD) ResearchLong-Term Effects of COVID-19COVID-19 Clinical Research Studies